Sign in

CIK 0001711279 · Large accelerated filer

Krystal Biotech, Inc.

Sign in to watch
Ticker
KRYS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
821080209
Phone
(412) 586-5830
Business address
2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$17,966,069
in 2 filings, $18.0M under 10b5-1 plans

Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −2,395 $200.98 $481K 1,563,062
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −800 $201.81 $161K 1,562,262
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −8,497 $195.43 $1.7M 1,517,385
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −2,727 $196.07 $535K 1,514,658
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −1,385 $197.55 $274K 1,513,273
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −3,392 $198.43 $673K 1,509,881
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −2,945 $199.22 $587K 1,506,936
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −4,159 $200.41 $834K 1,502,777
2024-09-12 Krishnan Krish S President and CEO Sale 10b5-1 −1,895 $201.52 $382K 1,500,882
2024-06-30 Mazzacco Catherine Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-30 Sutherland Everett Rand Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-30 Mason Christopher Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-30 JANNEY DANIEL Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-30 Gangolli Julian S Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-30 ROSSI DINO A Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-06-11 Krishnan Suma President, R&D Sale 10b5-1 −900 $171.40 $154K 1,549,982
2024-06-11 Krishnan Suma President, R&D Sale 10b5-1 −2,099 $172.24 $362K 1,547,883
2024-06-11 Krishnan Suma President, R&D Sale 10b5-1 −1,206 $173.41 $209K 1,546,677
2024-06-11 Krishnan Suma President, R&D Sale 10b5-1 −1,724 $174.50 $301K 1,544,953
2024-06-11 Krishnan Suma President, R&D Sale 10b5-1 −4,975 $175.33 $872K 1,539,978

Page 19 of 42 · 828 trades